Skip to content
healthcare.dev

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

NDC 70752-142, BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, tablet, from QUAGEN PHARMACEUTICALS LLC.

Product NDC
70752-142
Status
Listed
Labeler
QUAGEN PHARMACEUTICALS LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214287
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70752-142 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUTALBITAL50 mg/1
  • ACETAMINOPHEN325 mg/1
  • CAFFEINE40 mg/1

Pharmacologic classes

Barbiturate [EPC]; Barbiturates [CS]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Methylxanthine [EPC]; Xanthines [CS]

Package NDCNDC-11Package
70752-142-1070752014210100 TABLET in 1 BOTTLE, PLASTIC (70752-142-10)
70752-142-1470752014214500 TABLET in 1 BOTTLE, PLASTIC (70752-142-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/24813ec6-0111-4782-9182-a2b93501a2bc
  • NADAC price for package 70752014210

    GET /v1/drugs/nadac/70752014210
  • NADAC price for package 70752014214

    GET /v1/drugs/nadac/70752014214

Use it

Look up 70752-142 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70752-142 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70752-142. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.